195 related articles for article (PubMed ID: 36814925)
41. Infiltration of LPAR5
He Y; Zhou H; Huang X; Qu Y; Wang Y; Pei W; Zhang R; Chen S; You H
Front Immunol; 2022; 13():909932. PubMed ID: 36591220
[TBL] [Abstract][Full Text] [Related]
42. Identification of key monocytes/macrophages related gene set of the early-stage abdominal aortic aneurysm by integrated bioinformatics analysis and experimental validation.
Cheng S; Liu Y; Jing Y; Jiang B; Wang D; Chu X; Jia L; Xin S
Front Cardiovasc Med; 2022; 9():950961. PubMed ID: 36186997
[TBL] [Abstract][Full Text] [Related]
43. BMPR2 expression level is correlated with low immune infiltration and predicts metastasis and poor survival in osteosarcoma.
Cao H; Quan S; Zhang L; Chen Y; Jiao G
Oncol Lett; 2021 May; 21(5):391. PubMed ID: 33777214
[TBL] [Abstract][Full Text] [Related]
44. Comprehensive analysis of prognostic tumor microenvironment-related genes in osteosarcoma patients.
Hu C; Liu C; Tian S; Wang Y; Shen R; Rao H; Li J; Yang X; Chen B; Ye L
BMC Cancer; 2020 Aug; 20(1):814. PubMed ID: 32854645
[TBL] [Abstract][Full Text] [Related]
45. Identification of abnormally high expression of POGZ as a new biomarker associated with a poor prognosis in osteosarcoma.
Zheng S; Liu Y; Sun H; Jia J; Wu T; Ding R; Cheng X
Eur J Histochem; 2021 Sep; 65(3):. PubMed ID: 34474553
[TBL] [Abstract][Full Text] [Related]
46. Identification and verification of a BMPs-related gene signature for osteosarcoma prognosis prediction.
Xie L; Zeng J; He M
BMC Cancer; 2023 Feb; 23(1):181. PubMed ID: 36814224
[TBL] [Abstract][Full Text] [Related]
47. Expression of immune-related genes as prognostic biomarkers for the assessment of osteosarcoma clinical outcomes.
Guo J; Li X; Shen S; Wu X
Sci Rep; 2021 Dec; 11(1):24123. PubMed ID: 34916564
[TBL] [Abstract][Full Text] [Related]
48. The prognostic value and immune landscapes of m1A/m5C/m6A-associated lncRNA signature in osteosarcoma.
Wu ZY; Shi ZY
Eur Rev Med Pharmacol Sci; 2022 Aug; 26(16):5868-5883. PubMed ID: 36066162
[TBL] [Abstract][Full Text] [Related]
49. Integrated analysis of anti-tumor roles of BAP1 in osteosarcoma.
Hu D; Zheng Y; Ou X; Zhang L; Du X; Shi S
Front Oncol; 2022; 12():973914. PubMed ID: 36003792
[TBL] [Abstract][Full Text] [Related]
50. A cuproptosis-related genes signature associated with prognosis and immune cell infiltration in osteosarcoma.
Yang W; Wu H; Tong L; Wang Y; Guo Q; Xu L; Yan H; Yin C; Sun Z
Front Oncol; 2022; 12():1015094. PubMed ID: 36276092
[TBL] [Abstract][Full Text] [Related]
51. The Role of NR4A1 in the Pathophysiology of Osteosarcoma: A Comprehensive Bioinformatics Analysis of the Single-Cell RNA Sequencing Dataset.
Liu W; Hao Y; Tian X; Jiang J; Qiu Q
Front Oncol; 2022; 12():879288. PubMed ID: 35965537
[TBL] [Abstract][Full Text] [Related]
52. [Bioinformatics Analysis on Key Genes and Immune Infiltration of Osteosarcoma].
Li S; Zheng ZZ; Zhang YP; Liu ZQ; Xiao SP; Ouyang ZX; Wang B
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Feb; 44(1):110-117. PubMed ID: 35300772
[TBL] [Abstract][Full Text] [Related]
53. Pathways of immune exclusion in metastatic osteosarcoma are associated with inferior patient outcomes.
Ligon JA; Choi W; Cojocaru G; Fu W; Hsiue EH; Oke TF; Siegel N; Fong MH; Ladle B; Pratilas CA; Morris CD; Levin A; Rhee DS; Meyer CF; Tam AJ; Blosser R; Thompson ED; Suru A; McConkey D; Housseau F; Anders R; Pardoll DM; Llosa N
J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34021032
[TBL] [Abstract][Full Text] [Related]
54. Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of osteosarcoma.
Zhang C; Zheng JH; Lin ZH; Lv HY; Ye ZM; Chen YP; Zhang XY
Aging (Albany NY); 2020 Feb; 12(4):3486-3501. PubMed ID: 32039832
[TBL] [Abstract][Full Text] [Related]
55. Multi-Omics Analysis Showed the Clinical Value of Gene Signatures of C1QC
Li X; Zhang Q; Chen G; Luo D
Front Immunol; 2021; 12():694801. PubMed ID: 34295336
[TBL] [Abstract][Full Text] [Related]
56. SLC19A1 May Serve as a Potential Biomarker for Diagnosis and Prognosis in Osteosarcoma.
Li C; Yuan B; Yu X; Ju L; Ma Y; Guo D; Zhang K
Clin Lab; 2020 Nov; 66(11):. PubMed ID: 33180421
[TBL] [Abstract][Full Text] [Related]
57. Exploring the impact of PDGFD in osteosarcoma metastasis through single-cell sequencing analysis.
Huang Y; Cao D; Zhang M; Yang Y; Niu G; Tang L; Shen Z; Zhang Z; Bai Y; Min D; He A
Cell Oncol (Dordr); 2024 Apr; ():. PubMed ID: 38652223
[TBL] [Abstract][Full Text] [Related]
58. Exploration and Validation of a Novel Inflammatory Response-Associated Gene Signature to Predict Osteosarcoma Prognosis and Immune Infiltration.
Fu Y; He G; Liu Z; Wang J; Zhang Z; Bao Q; Wen J; Jin Z; Zhang W
J Inflamm Res; 2021; 14():6719-6734. PubMed ID: 34916821
[TBL] [Abstract][Full Text] [Related]
59. Identification of PSMD14 as a potential novel prognosis biomarker and therapeutic target for osteosarcoma.
Gong Y; Wei ZR
Cancer Rep (Hoboken); 2022 Jul; 5(7):e1522. PubMed ID: 34383385
[TBL] [Abstract][Full Text] [Related]
60. Comprehensive Analysis of a ceRNA Network Identifies lncR-C3orf35 Associated with Poor Prognosis in Osteosarcoma.
Shi Y; Ren J; Zhuang Z; Zhang W; Wang Z; Liu Y; Li J; Liang T; He R; Wang K
Biomed Res Int; 2020; 2020():3178037. PubMed ID: 33015161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
